Bank of New York Mellon Corp - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$86,548,000
+36.8%
502,898
-0.3%
0.02%
+41.7%
Q2 2021$63,288,000
-14.2%
504,333
-7.2%
0.01%
-20.0%
Q1 2021$73,723,000
+19.3%
543,646
+12.6%
0.02%
+15.4%
Q4 2020$61,778,000
+20.2%
482,864
+5.7%
0.01%0.0%
Q3 2020$51,401,000
+64.3%
456,782
+39.1%
0.01%
+62.5%
Q2 2020$31,286,000
-3.0%
328,389
-8.5%
0.01%
-27.3%
Q1 2020$32,256,000
-17.5%
358,905
-51.3%
0.01%
+10.0%
Q4 2019$39,112,000
+34.4%
737,693
+0.2%
0.01%
+25.0%
Q3 2019$29,096,000
+48.5%
736,462
+54.4%
0.01%
+60.0%
Q2 2019$19,595,000
-13.0%
477,016
-1.4%
0.01%
-16.7%
Q1 2019$22,531,000
+17.7%
483,811
+10.0%
0.01%0.0%
Q4 2018$19,147,000
+76.6%
439,644
+132.1%
0.01%
+100.0%
Q3 2018$10,839,000
+30.6%
189,390
+10.7%
0.00%
+50.0%
Q2 2018$8,302,000
+27.8%
171,104
+3.0%
0.00%0.0%
Q1 2018$6,494,000
-7.3%
166,076
+0.7%
0.00%0.0%
Q4 2017$7,002,000
+13.2%
164,959
-0.4%
0.00%0.0%
Q3 2017$6,183,000
+46.8%
165,645
+19.5%
0.00%
+100.0%
Q2 2017$4,211,000
+32.2%
138,561
+15.2%
0.00%0.0%
Q1 2017$3,185,000
-8.0%
120,292
-11.3%
0.00%0.0%
Q4 2016$3,462,000
-27.5%
135,621
+2.9%
0.00%0.0%
Q3 2016$4,772,000
+2.0%
131,861
-4.2%
0.00%0.0%
Q2 2016$4,679,000
+34.5%
137,689
+4.5%
0.00%0.0%
Q1 2016$3,478,000
-33.4%
131,723
+22.9%
0.00%
-50.0%
Q4 2015$5,225,000
+117.3%
107,145
+11.0%
0.00%
+100.0%
Q3 2015$2,404,000
-18.6%
96,530
+3.4%
0.00%0.0%
Q2 2015$2,954,000
+7.8%
93,359
+29.6%
0.00%0.0%
Q1 2015$2,741,000
+0.4%
72,032
+2.9%
0.00%0.0%
Q4 2014$2,729,000
+33.4%
70,021
+3.5%
0.00%0.0%
Q3 2014$2,046,000
-50.4%
67,660
-44.2%
0.00%0.0%
Q2 2014$4,122,000
+264.1%
121,304
+269.9%
0.00%
Q1 2014$1,132,000
+27.8%
32,795
+46.6%
0.00%
Q4 2013$886,00022,3670.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders